Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS genome editing platform.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2022
Mar 2019
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
